Tag Archives: Genetic Engineering and Biotechnology News

Patients lose, lawyers win, as AbbVie does deal with Amgen to delay Humira biosim.

The News: Amgen Inc. (Thousand Oaks CA) has agreed to delay the US launch of its FDA-approved biosimilar version of AbbVie Inc.’s (North Chicago) Humira (adalimumab) until 2023, under a… Read more »

Kite submits IND for CAR-T multiple myeloma treatment; Novartis keeping wary eye on rival’s latest move in high-stakes race.

The News: Kite Pharma Inc. (Santa Monica CA) said it has submitted to the FDA an Investigational New Drug (IND) application to launch a Phase 1, first-in-human trial of a… Read more »

Insys crashes back to earth as top execs arrested; what were they thinking?

The former CEO and president of Insys Therapeutics Inc. (Chandler AZ) was among six former company executives who were arrested last Thursday (December 8, 2016) on federal charges of leading… Read more »